Cite
HARVARD Citation
Tarpgaard, L. et al. (2016). A phase II study of Epirubicin in oxaliplatin-resistant patients with metastatic colorectal cancer and TOP2A gene amplification. BMC cancer. 16 (1), pp. 1-5. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tarpgaard, L. et al. (2016). A phase II study of Epirubicin in oxaliplatin-resistant patients with metastatic colorectal cancer and TOP2A gene amplification. BMC cancer. 16 (1), pp. 1-5. [Online].